Renejix CDMO Partner for Small Molecule Oral Dosage Forms Renejix CDMO Partner for Small Molecule Oral Dosage Forms

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for NKGen Biotech

    Client Virtual Booth

    NKGEN BIOTECH

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    NKGen Biotech
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3001 Daimler St, Santa Ana, California 92705
    Telephone
    Telephone
    949-396-6830
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://nkgenbiotech.com/about-us/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/nkgen-biotech-inc/
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    NKGen Biotech Receives Notification From Nasdaq Related to Delayed Report
    NKGen Biotech Receives Notification From Nasdaq Related to Delayed Report

    https://www.globenewswire.com/news-release/2024/08/22/2934619/0/en/NKGen-Biotech-Receives-Notification-From-Nasdaq-Related-to-Delayed-Quarterly-Report.html

    GLOBENEWSWIRE
    22 Aug 2024
    Share Share
    NKGen Biotech Presents SNK01 Biomarker Data At AAIC 2024
    NKGen Biotech Presents SNK01 Biomarker Data At AAIC 2024

    https://www.globenewswire.com/news-release/2024/07/30/2920975/0/en/NKGen-Biotech-Presents-New-Positive-SNK01-Biomarker-Data-at-the-2024-Alzheimer-s-Association-International-Conference.html

    GLOBENEWSWIRE
    30 Jul 2024
    Share Share
    NKGen Biotech To Present SNK01 Alzheimer's Trial Data At 2024 Conference
    NKGen Biotech To Present SNK01 Alzheimer's Trial Data At 2024 Conference

    https://www.globenewswire.com/news-release/2024/07/18/2915247/0/en/NKGen-Biotech-to-Present-New-Positive-SNK01-Clinical-Trial-Biomarker-Data-at-the-2024-Alzheimer-s-Association-International-Conference.html

    GLOBENEWSWIRE
    18 Jul 2024
    Share Share
    NKGen Biotech Appoints Dr. Marco Gottardis to its Board of Directors
    NKGen Biotech Appoints Dr. Marco Gottardis to its Board of Directors

    https://www.globenewswire.com/news-release/2024/07/15/2913027/0/en/NKGen-Biotech-Appoints-Dr-Marco-Gottardis-to-its-Board-of-Directors.html

    GLOBENEWSWIRE
    15 Jul 2024
    Share Share
    NKGen Biotech Presents Updated Phase 1 Data On SNK02 At Summit
    NKGen Biotech Presents Updated Phase 1 Data On SNK02 At Summit

    https://www.globenewswire.com/news-release/2024/06/12/2897817/0/en/NKGen-Biotech-Presents-Updated-Phase-1-Data-on-SNK02-Allogeneic-NK-Cell-Therapy-for-Solid-Tumors-at-the-6th-Annual-Allogeneic-Cell-Therapies-Summit-2024.html

    GLOBENEWSWIRE
    12 Jun 2024
    Share Share
    NKGen To Present SNK02 Allo NK Cell Therapy Phase 1 Solid Tumor Data
    NKGen To Present SNK02 Allo NK Cell Therapy Phase 1 Solid Tumor Data

    https://www.globenewswire.com/news-release/2024/06/03/2892223/0/en/NKGen-Biotech-To-Present-Updated-Phase-1-Data-on-SNK02-Allogeneic-NK-Cell-Therapy-in-Solid-Tumors-at-the-6th-Annual-Allogeneic-Cell-Therapies-Summit-2024.html

    GLOBENEWSWIRE
    03 Jun 2024
    Share Share
    Nkgen Snk02 Nk Phase 1: Advanced Solid Tumors At Asco 2024
    Nkgen Snk02 Nk Phase 1: Advanced Solid Tumors At Asco 2024

    https://www.globenewswire.com/news-release/2024/05/23/2887701/0/en/NKGen-Biotech-Publishes-Phase-1-Interim-Analysis-Results-of-SNK02-Allogeneic-NK-Cell-Therapy-in-Advanced-Solid-Tumors-at-the-2024-American-Society-of-Clinical-Oncology-ASCO-Annual-.html

    GLOBENEWSWIRE
    23 May 2024
    Share Share
    NKGen's SNK01 NK Cleared For Alzheimer's Phase 2 Trial
    NKGen's SNK01 NK Cleared For Alzheimer's Phase 2 Trial

    https://www.globenewswire.com/news-release/2024/05/20/2884834/0/en/NKGen-Biotech-s-SNK01-NK-Cell-Therapy-Cleared-to-Start-Phase-2-Clinical-Trial-in-Alzheimer-s-Disease.html

    GLOBENEWSWIRE
    20 May 2024
    Share Share
    NKGen Biotech To Present On Autologous NK Cell Therapy
    NKGen Biotech To Present On Autologous NK Cell Therapy

    https://www.globenewswire.com/news-release/2024/05/16/2883377/0/en/NKGen-Biotech-Announces-Upcoming-Presentation-on-Autologous-NK-Cell-Therapy-at-the-5th-International-Cell-Gene-Therapy-China-Summit-Exhibition.html

    GLOBENEWSWIRE
    16 May 2024
    Share Share
    NKGen Biotech Gets FDA IND Clearance for SNK01 in Parkinson's
    NKGen Biotech Gets FDA IND Clearance for SNK01 in Parkinson's

    https://www.globenewswire.com/news-release/2024/04/29/2871205/0/en/NKGen-Biotech-Announces-FDA-Clearance-of-Investigational-New-Drug-IND-Application-for-SNK01-NK-Cell-Therapy-in-Parkinson-s-Disease.html

    GLOBENEWSWIRE
    29 Apr 2024
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    farmak-a-s-m-2024-08-26

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search